HighMark Wealth Management LLC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 32 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$21,000
-54.3%
80,0940.0%0.02%
-51.4%
Q2 2022$46,000
-13.2%
80,0940.0%0.04%
+5.7%
Q1 2022$53,000
-38.4%
80,0940.0%0.04%
-36.4%
Q4 2021$86,000
-17.3%
80,0940.0%0.06%
-28.6%
Q3 2021$104,000
-34.6%
80,0940.0%0.08%
-34.2%
Q2 2021$159,000
-26.4%
80,0940.0%0.12%
-32.0%
Q1 2021$216,00080,0940.17%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders